49 results
8-K
EX-99.1
RVMD
Revolution Medicines Inc
6 Nov 23
Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
4:05pm
manner or at all and the effects on the company’s business of the COVID-19 pandemic and other global events. For a further description of the risks
8-K
EX-99.1
btymhs7
8 Aug 23
Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
4:04pm
425
0dah06v kxpf
1 Aug 23
Business combination disclosure
5:11pm
8-K
EX-99.1
1y400n c9t
8 May 23
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
4:04pm
8-K
EX-99.1
dosw88ovdivjzb6
7 Nov 22
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
4:08pm
8-K
EX-99.1
hqxabryk0tbnzxx36kaq
9 Aug 22
Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress
12:00am
424B5
mqjsei xj
20 Jul 22
Prospectus supplement for primary offering
4:02pm
424B5
8c1tzlshmm5bg
19 Jul 22
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
ge2 qn6swd7lqhk30
9 May 22
Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress
4:07pm